Related Experiment Video
Updated: Jun 12, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Hispolon promotes MDM2 downregulation through chaperone-mediated autophagy
Te-Ling Lu1, Guan-Jhong Huang, Huang-Joe Wang
1School of Pharmacy, China Medical University, Taichung, Taiwan.
Abstract:
Amplification and overexpression of murine double minute (MDM2) has been observed in several human cancers. Some chemotherapeutic agents cause MDM2 ubiquitination and degradation in a proteasome-dependent system. In addition to the proteasome system, chaperone-mediated autophagy (CMA) is a lysosomal pathway for selective misfolded protein degradation. Molecular chaperone heat shock cognate 70 protein (Hsc70) recognizes the misfolded proteins, which are then delivered to lysosome-associated membrane protein type 2A (LAMP2A) for lysosomal degradation. Our previous study reported that hispolon was able to induce cell apoptosis and downregulate MDM2 expression. In this study, our results showed that the proteasome inhibitor, MG132, could not inhibit hispolon-induced MDM2 downregulation. In contrast, both inhibition of lysosomes with NH(4)Cl and inhibition of LAMP2A using siRNA partially attenuated hispolon-induced MDM2 downregulation. To determine whether Hsc70 recognizes MDM2 on amino acids 135-141, SMP14 antibody was used to compete with Hsc70 for interaction with MDM2. After Hsc70 knockdown, SMP14 antibody immunoprecipitated increased MDM2. We also found that hispolon induced increased association of Hsp70, Hsc70, Hsp90 and LAMP2A with MDM2. This association was inhibited in cells pretreated with geldanamycin (GA), an Hsp90 inhibitor. GA also attenuated hispolon-induced MDM2 downregulation. Meanwhile, inhibition of Hsc70 using siRNA attenuated hispolon-induced MDM2 downregulation. Our study provides the first example of the ability of hispolon to mediate MDM2 downregulation in lysosomes through the CMA pathway.
Insights
Hispolon triggers cancer-related MDM2 protein downregulation via chaperone-mediated autophagy (CMA), a lysosomal degradation pathway. This study reveals a novel mechanism for controlling MDM2 levels in cancer cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Murine double minute (MDM2) amplification and overexpression are implicated in human cancers.
- While some chemotherapeutics target MDM2 via proteasomal degradation, alternative pathways may exist.
- Chaperone-mediated autophagy (CMA) is a lysosomal pathway for selective protein degradation involving Hsc70 and LAMP2A.
Purpose of the Study:
- To investigate the mechanism by which hispolon downregulates MDM2 expression.
- To determine if MDM2 degradation occurs through the proteasome or CMA pathway.
- To elucidate the role of Hsc70 and LAMP2A in hispolon-induced MDM2 downregulation.
Main Methods:
- Utilized proteasome inhibitor MG132 and lysosomal inhibitors (NH(4)Cl, siRNA targeting LAMP2A).
- Assessed MDM2 levels and protein interactions using immunoprecipitation and Western blotting.
- Investigated Hsc70-MDM2 interaction using SMP14 antibody and Hsc70 knockdown.
- Examined the effect of Hsp90 inhibitor geldanamycin (GA) on hispolon-induced effects.
Main Results:
- Hispolon-induced MDM2 downregulation was not affected by MG132 but was partially attenuated by lysosomal inhibition and LAMP2A knockdown.
- Hsc70 knockdown increased MDM2 immunoprecipitation by SMP14 antibody, suggesting Hsc70 interaction.
- Hispolon increased the association of Hsp70, Hsc70, Hsp90, and LAMP2A with MDM2.
- Geldanamycin and Hsc70 siRNA inhibited hispolon-induced MDM2 downregulation.
Conclusions:
- Hispolon downregulates MDM2 expression through the chaperone-mediated autophagy (CMA) lysosomal degradation pathway.
- This represents the first evidence of hispolon utilizing CMA for MDM2 downregulation.
- The findings highlight a novel therapeutic strategy targeting MDM2 in cancer via CMA modulation.
Related Concept Videos
Abnormal Proliferation
Export of Misfolded Proteins out of the ER
The Unfolded Protein Response
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
